/A

Conditions: 104 patients will be randomized to each of the two groups to apply TAP or femoral block, after which they were placed in lateral decubitus position and proceed to the performance of spinal anesthesia. The group will perform TAP TAP block with 30 ml of levobupivacaine 0.125% and the femoral group perform femoral block, levobuivacaína injecting 10 ml of 0.25%. Both blocks will be guided by ultrasound.
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]

Registration Number: EUCTR2011-004167-68-ES

Lead Sponsor: MARIA TERESA PARRAS MALDONADO

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Authorised-recruitment may be ongoing or finished

Sex: All

Target Recruitment: 104

Inclusion Criteria

inclusion criteria:
- Sing of consent
- More than 65 years old
- ASA clasification (I-III) for anestesic risk
- Hip fracture with parcial arthroplasty surgical treatment
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 104

Exclusion Criteria

exclusion criteria:
- Anestesic allergy
- Mental illness
- Periferic neuropathy
- Intradural anesthetic contraindication

Study & Design

Study Type: Interventional clinical trial of medicinal product

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: To evaluate effectiveness of postoperative analgesic in TAP block versus femoral block in hip fracture;Secondary Objective: - To analyze the necessity of postoperative analgesic <br>- To value the effectiveness of block between both group<br>- To compare their stay in URPA<br>- To value the satisfaction in the patient;Primary end point(s): After the surgery and the patient extubated, will move into the recovery room post-anesthesia (PACU).;Timepoint(s) of evaluation of this end point: In PACU the patient will pass the EVA survey to analyze the degree of pain.

Secondary Outcome Measures